Evidence map›Paper›PMID 32084249›Full record

ArticlePloS one2020

HelixComplex snail mucus as a potential technology against O3 induced skin damage.

Valentina Gentili, Daria Bortolotti, Mascia Benedusi, Andrea Alogna, Anna Fantinati, Anna Guiotto, Giulia Turrin, Carlo Cervellati, Claudio Trapella, Roberta Rizzo and 1 more

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Chemical Variability and Biological Potential ofMolecules (Basel, Switzerland) · 2025
    Review
  3. Unveiling the therapeutic journey of snail mucus in diabetic wound care.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  4. Hydroxypropyl-Methylcellulose and GlicoProOphthalmology and therapy · 2025
    Article
  5. Review
  6. Article
  7. Fabrication of BioactiveACS omega · 2024
    Article
  8. Article
  9. Development of CuO Nanoparticles from the Mucus of Garden SnailPharmaceuticals (Basel, Switzerland) · 2024
    Article
  10. A Novel Ophthalmic Solution Containing GlicoproJournal of clinical medicine · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Heliyon · 2023
    Article
  16. Recombinant mucin biotechnology and engineering.Advanced drug delivery reviews · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valentina GentiliDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.ORCID 0000-0003-4572-5497
Daria BortolottiDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Mascia BenedusiDepartment of Biomedical and Specialist Surgical Sciences, Section of Medical Biochemistry, Molecular Biology and Genetics, University of Ferrara, Ferrara, Italy.
Andrea AlognaDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Anna FantinatiDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Anna GuiottoDepartment of Biomedical and Specialist Surgical Sciences, Section of Medical Biochemistry, Molecular Biology and Genetics, University of Ferrara, Ferrara, Italy.
Giulia TurrinDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Carlo CervellatiDepartment of Biomedical and Specialist Surgical Sciences, Section of Medical Biochemistry, Molecular Biology and Genetics, University of Ferrara, Ferrara, Italy.
Claudio TrapellaDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Roberta RizzoDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.ORCID 0000-0001-9507-9126
Giuseppe ValacchiDepartment of Biomedical and Specialist Surgical Sciences, Section of Medical Biochemistry, Molecular Biology and Genetics, University of Ferrara, Ferrara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucus form H. aspersa muller has been reported to have several therapeutic proprieties, such as antimicrobial activity, skin protection and wound repair. In this study, we have analyzed H. aspersa mucus (Helixcomplex) bio-adhesive efficacy and its defensive properties against the ozone (O3) (0.5 ppm for 2 hours) exposure in human keratinocytes and reconstructed human epidermis models. Cytotoxicity, tissue morphology and cytokine levels were determined. We confirmed HelixComplex regenerative and bio-adhesive properties, the latter possibly via the characteristic mucopolysaccharide composition. In addition, HelixComplex was able to protect from O3 exposure by preventing oxidative damage and the consequent pro-inflammatory response in both 2D and 3D models. Based on this study, it is possible to suggest HelixComplex as a potentially new protective technology against pollution induced skin damage.

Indexed as

AnimalsCell LineCell SurvivalEpidermisHelix, SnailsHumansKeratinocytesMucusOxidation-ReductionOxidative StressWound Healing

Identifiers

PMID32084249
PMCPMC7034816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.